KNSA

NASD Kiniksa Pharmaceuticals International, plc Class A
Oct 10, 2026 · 5:06 AM ET EOD Market Closed

$79.78 ↑ +0.00 (+0.00%) Trading Up from the previous close of $79.78, $0.72 below the day’s high of $80.50

YTD change
+93.41%
vs 20-day SMA
+4.13%
vs 200-day SMA
+40.15%

Price ranges

Previous day
$78.03 $80.50
open $78.24 close $79.78
+$1.54 (+1.97%)
Today
$78.03 $80.50
$79.78
Past week
$73.84 $79.22
from $75.22 now $79.78
+$4.56 (+6.06%)
Past month
$73.14 $79.76
from $76.48 now $79.78
+$3.30 (+4.31%)
This year
$37.02 $82.94
from $41.25 now $79.78
+$38.53 (+93.41%)

Price & Performance

+32.70 (+69.46%) / 6M

$39.37$54.25$69.12$84.00Apr 10Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 3.8% away from all-time highs of $82.94
  • KNSA is up 93% since the beginning of the year
  • KNSA is up 109% over the past 12 months
  • KNSA is up 4% over the past 1 month
  • 8% of all KNSA investors are betting against KNSA

KNSA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +110.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.3
Earnings momentum +18.9% Quarterly EPS growth
Quarterly change +18.9%

Valuation

P/E ratio 79.55
Enterprise value $6.1B
Beta 0.08

Balance sheet & scale

Income$80.7K
Revenue$840.8M
Cash$525.9M
Debt$8.9K
Income / Debt 9.07×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.2B

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.